News Links
Daily Care News for August 17, 2016
The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes. Postpartum hypoglycemia is common in the immediate postpartum period in Type 1 diabetes. Contemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycemic control. Adherence to insulin therapeutic regimens in patients with type 1 diabetes. A nationwide survey in Brazil.
Read MoreResearch News From August 17, 2016
Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes. Effect of autoimmunity risk loci on the honeymoon phase in type 1 diabetes.
Read MorePress Releases for August 10, 2016
Capillary Biomedical Developing Improved Insulin Delivery Catheter with Funding Support from JDRF.
Read MorePopular Press for August 10, 2016
Barbara Davis Keeps the Carousel of Hope Charity Ball Turning. Back to School With Diabetes. Pump It Up Challenge educates Queensland school children about type 1 diabetes. Pediatric Endocrinologist Fosters Small Changes Every Day. FGCU swimmer Evita Leter overcomes diabetes to reach Olympics.
Read MoreCeliac News for August 10, 2016
A Comparison of Patients’ and Doctors’ Reports on Health Related Quality of Life in Celiac Disease. Elderly Onset Celiac Disease: A Narrative Review. Free full text available in HTML and PDF formats. Celiac Disease Presenting as Profound Diarrhea and Weight Loss – A Celiac Crisis.
Read MoreDaily Care News for August 10, 2016
Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes. See also Combination Therapy for Type 1 Diabetes Improves Blood Glucose Control. Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial. Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: the ADJUNCT TWO Randomized Trial. Adjunctive Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Type 1 Diabetes Mellitus. Evaluating Substance Use and Insulin Misuse in Adolescents With Type 1 Diabetes. Stress and Coping Predicts Adjustment and Glycemic Control […]
Read MoreResearch News From August 10, 2016
Islet transplantation provides superior glycemic control with less hypoglycemia compared to continuous subcutaneous insulin infusion (CSII) or multiple daily insulin injections (MDI). Well, I Wouldn’t be Any Worse Off, Would I, Than I am Now? A Qualitative Study of Decision-Making, Hopes, and Realities of Adults With Type 1 Diabetes Undergoing Islet Cell Transplantation. Duration of Action of Two Insulin Glargine Products, LY2963016 Insulin Glargine and Lantus® Insulin Glargine, in Subjects with Type 1 Diabetes Mellitus. Lipid Changes During Basal Insulin Peglispro, Insulin Glargine, or NPH Treatment in 6 IMAGINE Trials. Is there a role for gut microbiota in type 1 […]
Read MorePress Releases for August 3, 2016
Companion Medical Receives FDA Clearance for Smart Insulin Delivery System.
Read More